OncoSec Medical, Inc. (ONCS)

Oncology Corporate Profile

Stock Performance

1.8800
-0.1100

HQ Location

9810 Summers Ridge Road, Suite 110
San Diego, CA 92121

Company Description

OncoSec Medical Inc. is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors. ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy, and other treatment alternatives.

Website: http://www.oncosec.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
ImmunoPulseimmunotherapyMetastatic MelanomaII
ImmunoPulseimmunotherapyTriple negative Breast cancerII
ImmunoPulse (+pembrolizumab)immunotherapyMetastatic MelanomaII

View additional information on product candidates here »

Source: http://www.oncosec.com

Recent News Headlines

7/20/2017 06:19 pm

7/20/2017 06:19 pm

7/20/2017 06:19 pm

7/20/2017 06:19 pm

7/20/2017 06:19 pm

7/4/2017 06:19 am

7/4/2017 06:19 am

7/4/2017 06:19 am

6/27/2017 06:19 am

6/27/2017 06:19 am

6/12/2017 12:19 am

6/12/2017 12:19 am

6/12/2017 12:19 am

6/8/2017 12:19 pm

6/8/2017 12:19 pm

6/8/2017 12:19 pm

6/8/2017 12:19 pm

6/8/2017 12:19 pm

6/2/2017 12:19 am

6/1/2017 12:19 pm

5/11/2017 12:18 am

5/10/2017 12:18 am

5/8/2017 12:18 am

5/2/2017 06:18 am

4/11/2017 06:17 am